SAN FRANCISCO, Oct. 23, 2017 /PRNewswire/ -- Perricone MD, the leading premium dermatological skincare brand, renowned for its scientifically advanced cosmeceutical skincare and supplement portfolio, announces the appointment of Chief Executive Officer Ron Fugate to lead the brand through its next stage of growth.
"We took considerable time to identify the right leader who will bring Perricone MD to the next level in this rapidly changing and dynamic advanced skincare market," said Lion Capital LLP Partner and Managing Director Mary Minnick. "We're excited and confident in Ron's ability to put the consumer first, and to serve as an agile decision-maker who will successfully continue to define and grow Perricone MD's holistic brand vision among our brand loyalists and new consumers alike."
Ron Fugate joins the Perricone MD team as a highly experienced CEO with a strong background in consumer-driven companies. He has led multiple private equity and family-owned mid-market CPG companies, taking them through transformational growth and subsequent successful sale to strategic acquirers. "I'm incredibly honored to have been granted the opportunity to serve as the CEO of this iconic skincare brand," said Ron Fugate. "Perricone MD's assortment of powerful skincare solutions has a strong consumer reputation, and I look forward to identifying new ways to evolve and grow the brand to become even stronger. That will come from finding new ways to resonate with our target consumer, and by making the brand's health-centric proposition more relevant than ever."
Ron's diverse range of expertise spans an impressive mix of large, multi-national conglomerates and smaller startup brands in the health and personal care categories, making him the ideal leader for the brand. Most recently, Ron served as CEO of Renew Life, a Swander Pace-backed provider of natural products for digestive health and led the brand through a $290 million sale to Clorox in May 2016. Prior to Renew Life, Ron was hired by Catterton in 2013 to serve as the President of YoCrunch, which led to its sale to Danone. From 2006 to 2012, Ron served as the CEO of Alacer (the producer of Emergen-C), which led to its sale to Pfizer for $300m.
About Perricone MD
Celebrating 20 Years Younger
Since 1997, Perricone MD has maintained its commitment to advanced skincare research and to being as uncompromising about quality and potency as their customers are. To solve diverse skin concerns, Perricone MD uses science to identify and multiply the natural building blocks of youthful skin to deliver targeted results—now and over time.
Renowned for delivering dramatic clinically tested results, Perricone MD products feature the following award-winning signature sciences: H2 Energy Complex, Nrf2 Antioxidant Support Complex, DMAE, Alpha Lipoic Acid, Vitamin C Ester and Neuropeptides. Perricone MD products are available on perriconemd.com and a flagship store in Berkeley, CA, as well as at Sephora, Ulta, Nordstrom, Neimanmarcus.com and other leading specialty stores in the US. Perricone MD products are also available in more than 21 countries around the world.
SOURCE Perricone MD